This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
What's New in Managing Insomnia? Essentials for Primary Care

What's New in Managing Insomnia? Essentials for Primary Care

Format

Monograph

Time to Complete

1.25 hours

Released

October 28, 2016

Expires

October 28, 2017
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 Credit(s)TM
1.20 / ANCC Contact Hours (1.20 contact hours of pharmacotherapy credit)

Accredited Provider

This activity is jointly provided by Postgraduate Institute for Medicine and MedEdicus LLC.

Commercial Supporter

This activity is supported by an independent educational grant from Merck & Co, Inc.

Program Description

Insomnia is a common problem which adversely affects patient quality of life and increases the risk for morbidity and even mortality. The evolution of insomnia management is ongoing, but key advancements have placed primary care clinicians in the position of being able to provide tailored, effective treatment for struggling patients. In order to optimize patient outcomes, clinicians should be aware of the latest developments in insomnia diagnosis and treatment. This activity encompasses didactic and case-based learning, with expert commentary to help clinicians with the development of individualized management plans.

Target Audience

This activity is intended for primary care physicians, physician assistants, nurse practitioners, and registered nurses.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Assess patients for type of insomnia disorder
  • Review the mechanism of action, efficacy, and safety of new pharmacologic treatments for insomnia disorder
  • Choose insomnia therapy based on individual patient sleep patterns
  • Select appropriate dose of pharmacologic therapy for insomnia
  • Develop individualized management plans for a variety of patients with insomnia

Media

Internet

Conflict Of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Larry Culpepper, MD, MPH
Professor of Family Medicine
Department of Family Medicine
Boston University School of Medicine
Boston, Massachusetts

Dr. Culpepper had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consulting Fees (e.g., advisory boards): Allergan; Edgemont Pharmaceuticals, LLC; H Lundbeck A/S; Ironshore Pharmaceuticals; Merck & Co, Inc; Rhodes Pharmaceuticals; Shire; and Takeda Pharmaceutical Company Limited.
Wendy L. Wright, MSN, APRN, ANP/FNP, FAANP, FAAN
Owner
Wright & Associates Family Healthcare, PLLC
Amherst, New Hampshire
Concord, New Hampshire

Ms. Wright had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consulting Fees (e.g., advisory boards): Arbor Pharmaceuticals; Merck & Co, Inc; and Pfizer Inc; Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers’ bureaus): Merck & Co, Inc; sanofi-aventis U.S. LLC; and Takeda Pharmaceutical Company Limited.

Planners' and Managers' Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following MedEdicus planners and managers, Robert M. Geist IV, MD, Diane McArdle, PhD, Cynthia Tornallyay, RD, MBA, CHCP, and Michelle Ong have no real or apparent conflicts of interest to report.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and MedEdicus. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.20

Type

CE for Nurses

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.20 contact hours is provided by Postgraduate Institute for Medicine.

Designated for 1.20 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Disclosure of Unlabeled Use

This educational activity might contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation and Request for Credit

There are no fees for participating in and receiving CME/CE credit for this activity. During the period October 31, 2016, through October 31, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation online. Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, a certificate will be made available immediately.

If you have any questions relating to the certification of this activity, please contact Postgraduate Institute for Medicine via www.pimed.com.

For any CME-related questions, please call (201) 799-4827 or email cmequestions@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue